|
Volumn 9, Issue 4, 1996, Pages 159-162
|
Cost-effectiveness of inhaled β-agonists v. oral salbutamol in asthma: A randomized double-blind cross-over study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
PLACEBO;
SALBUTAMOL;
TERBUTALINE;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG COST;
FEMALE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MALE;
ORAL DRUG ADMINISTRATION;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, INHALATION;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADRENERGIC BETA-AGONISTS;
ADULT;
AGED;
ALBUTEROL;
ASTHMA;
BRONCHODILATOR AGENTS;
COST-BENEFIT ANALYSIS;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INDIA;
MALE;
MIDDLE AGED;
QUALITY OF LIFE;
TERBUTALINE;
|
EID: 0029900001
PISSN: 0970258X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (8)
|